Quarterly report pursuant to Section 13 or 15(d)

Fraunhofer Settlement (Narrative) (Details)

v3.21.2
Fraunhofer Settlement (Narrative) (Details) - USD ($)
3 Months Ended 12 Months Ended
May 04, 2021
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Mar. 31, 2023
Mar. 01, 2023
Mar. 31, 2022
Mar. 01, 2022
Settlement receivable - current portion   $ 5,100,000   $ 5,100,000        
Settlement receivable - noncurrent portion   5,100,000   5,100,000        
Revenues   211,000 $ 410,000          
iBio, Inc. v. Fraunhofer USA, Inc. [Member] | Settled Litigation [Member]                
Settlement receivable - current portion   10,200,000            
Percentage of legal fees expected to be received 100.00%              
Estimated net cash recovery $ 10,200,000              
Settlement income       $ 10,200,000        
iBio, Inc. v. Fraunhofer USA, Inc. [Member] | Settled Litigation [Member] | License and Maintenance [Member]                
Revenues   $ 1,800,000            
iBio, Inc. v. Fraunhofer USA, Inc. [Member] | Settled Litigation [Member] | Scenario, Plan [Member]                
Cash payments receivables related to litigation settlement 28,000,000              
iBio, Inc. v. Fraunhofer USA, Inc. [Member] | Settled Litigation [Member] | Scenario Plan Expected Legal Fees [Member]                
Cash payments receivables related to litigation settlement $ 16,000,000              
iBio, Inc. v. Fraunhofer USA, Inc. [Member] | Settled Litigation [Member] | Scenario Plan Expected Payment One [Member]                
Cash payments receivables related to litigation settlement               $ 900,000
iBio, Inc. v. Fraunhofer USA, Inc. [Member] | Settled Litigation [Member] | Scenario Plan Expected Payment One [Member] | License and Maintenance [Member]                
Settlement receivable - current portion             $ 5,100,000  
iBio, Inc. v. Fraunhofer USA, Inc. [Member] | Settled Litigation [Member] | Scenario Plan Expected Payment Two [Member]                
Cash payments receivables related to litigation settlement           $ 900,000    
iBio, Inc. v. Fraunhofer USA, Inc. [Member] | Settled Litigation [Member] | Scenario Plan Expected Payment Two [Member] | License and Maintenance [Member]                
Settlement receivable - noncurrent portion         $ 5,100,000